COVID-19 Jab Manufacturer AstraZeneca Admits For First Time Shot CAN Cause Blood Clotting
Editor's Note: Right. "In very rare cases."
AstraZeneca, for the first time, admitted its experimental COVID-19 shot can cause a potentially deadly side effect.
The UK-based COVID-19 jab manufacturer acknowledged in legal documents submitted to the United Kingdom High Court that its shot “can, in very rare cases, cause TTS.”
TTS stands for thrombosis with thrombocytopenia syndrome – a medical condition characterized by blood clot formation combined with a low platelet count.
“The admittance, as per the Telegraph, could pave the way for a multi-million-pound legal payout,” WION reports.
Daily Mail reports that dozens of families allege they, or their loved ones, were “maimed or killed” by AstraZeneca’s COVID-19 injection.
“Lawyers representing the claimants believe some of the cases could be worth up to £20m in compensation,” the outlet noted.
🚨AstraZeneca finally admits for the first time that the COVID Vax is unsafe, results in BLOOD-CLOTTING https://t.co/KqVGAmbTDO pic.twitter.com/uktC1jDT1l
— Gabrielle Cuccia (@its_gabbygabs) April 29, 2024
Per Daily Mail:
The complication – listed as a potential side effect of the jab – has previously been called vaccine-induced immune thrombotic thrombocytopenia (VITT).
AstraZeneca’s admission could lead to pay-outs on a case-by-case basis.
Although accepted as a potential side effect for two years, it marks the first time the company has admitted in court that its jab can cause the condition, The Telegraph reports.
Taxpayers will foot the bill of any potential settlement because of an indemnity deal AstraZeneca struck with the Government in the darkest days of Covid to get the jabs produced as quickly as possible while the country was paralysed by lockdowns.
It comes just days after the firm reported a revenue exceeding £10billion in the first quarter of 2024, a rise of 19 per cent. Company officials stated it had enjoyed a ‘very strong start’ to the year.
Breaking: AstraZeneca admits Its for the first time ever that their vaccines can cause side effects. The vaccine has also killed several people and this could be a multimillion or billion dollar lawsuit #mRNA. pic.twitter.com/9vXEI92NhP
— Erin Elizabeth Health Nut News 🙌 (@unhealthytruth) April 28, 2024
Per WION:
The first case against the company was lodged by Jamie Scott, father of two, who was 44 when he received the vaccine. Ten days after the jab, Scott complained of tiredness and started vomiting. Soon after, his speech got impaired, and he had to be taken to the hospital, where physicians diagnosed him with a suspected case of Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT).
He survived the ordeal but was left with a permanent brain injury.
Alongside Scott, 51 cases have been lodged against the company, with victims and grieving relatives seeking damages estimated to be worth up to £100 million ($125.36 million).
Lawyers for the pharma giant, however, in a letter of response sent in May last year contended “we do not accept that TTS is caused by the vaccine at a generic level”.
However, in the document submitted in February this year, AstraZeneca said, “It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known.”
“Further, TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence.”
However, lawyers for the victims argue that AstraZeneca-Oxford vaccine is “defective” and that its efficacy has been “vastly overstated”. AstraZeneca has strongly denied these claims.
AstraZeneca faces up to £255million compensation bill for 'defective' Covid vaccine after pharma titan admitted it DOES cause ultra-rare blood clot side effect - as wife of victim says 'we're not going to give up' https://t.co/FFlHBVuPh2 pic.twitter.com/fFP8CBqMSR
— Daily Mail Online (@MailOnline) April 29, 2024
According to Daily Mail, researchers investigating the side effect theorize “it occurs due to the modified cold virus lurking in the jab acting like a magnet to a type of protein in the blood called platelet factor 4. Platelet factor 4 is normally used by the body to promote coagulation in the blood, in case of injury. Then, in rare instances, the body’s immune system confuses platelet factor 4 with a foreign invader and releases antibodies to attack it in case of ‘mistaken identity’. These antibodies then clump together with platelet factor 4, forming the blood clots that have become so heavily linked with the jab.”
